STOCK TITAN

Bioquest Corp Stock Price, News & Analysis

BQST OTC

Welcome to our dedicated page for Bioquest news (Ticker: BQST), a resource for investors and traders seeking the latest updates and insights on Bioquest stock.

BioQuest Corp (BQST) is a publicly traded company on the OTC Markets that has shifted its focus from biotechnology to conversational artificial intelligence and automation through its acquisition of BotMakers, Inc. The news surrounding BioQuest centers on this strategic evolution, its AI platform developments, and contracts that showcase the use of AI voice and messaging automation in real-world settings.

Recent announcements highlight BioQuest’s completion of the BotMakers acquisition and the appointment of new technology leadership to guide its AI automation strategy. Company news describes BotMakers as an AI-powered conversational technology platform aimed at enterprise-level solutions, including automated digital workforce tools for government agencies, corporations, and law enforcement organizations.

BioQuest’s news flow also features examples of commercial traction for BotMakers. These include a nationwide outbound AI voice campaign contract with Atlas Grants, a national platform that connects individuals and families with grants and financial aid, and a high-profile contract with 3Mark Financial for conversational AI deployment in the life insurance sector. Additional client references in company communications include organizations such as Infinity Concepts, Colonial Stock Transfer, United Israel Charity, Shield Funding, iHost Poker Casino Parties, Kid Fit Strong, and ProMarketing Leads.

Visitors to this page can review news items that describe BioQuest’s role in the conversational AI technology sector, its efforts to expand AI platform offerings into biotech, healthcare, and B2B markets, and its stated intention to rebrand as BotMakers, Inc. Monitoring these updates can help readers understand how the company presents its progress in AI automation, enterprise contracts, and strategic positioning over time.

Rhea-AI Summary

BioQuest Corp. (OTC:BQST) through its subsidiary BotMakers has secured a nationwide AI voice calling campaign contract with Atlas Grants. The partnership aims to leverage BotMakers' advanced conversational AI technology to connect Americans with grants, funding opportunities, and nonprofit assistance programs. The company's solution combines natural language voice agents with intelligent workflow automation to scale outreach operations efficiently.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-25.01%
Tags
AI
-
Rhea-AI Summary

BioQuest (OTC PINK:BQST) has appointed Ed Preble as Chief Technology Officer (CTO), following its recent acquisition of BotMakers, a conversational AI platform. This appointment marks BioQuest's strategic shift from biotechnology to AI automation technology.

Preble brings over 40 years of experience in technology innovation and business growth, with expertise in AI, SaaS, telecom automation, and enterprise infrastructure. He previously served as CEO of Affinity VoIP Telecom and was a professor of eCommerce at San Jose State University.

Following the BotMakers acquisition, BioQuest is expanding its AI-powered solutions including:

  • Conversational AI agents for lead engagement
  • Omnichannel social media automation
  • AI-generated funnels and CRM automations
  • Biotech-specific AI solutions for clinical communication

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.76%
Tags
management
-
Rhea-AI Summary

BioQuest (OTC PINK:BQST) has completed its acquisition of BotMakers, a leader in AI-powered conversational technology, and appointed Trent T. Daniel as CEO. The company, trading above $1 per share, previously secured SEC clearance for a $5 million Regulation A offering to fund marketing and platform development.

BotMakers expects to generate revenues exceeding $1.2 million this year, targeting $5 million by end-2026. The company serves notable clients including Infinity Concepts and Colonial Stock Transfer. BotMakers secured a contract with 3Mark Financial for implementing conversational AI technology.

BioQuest plans to rebrand as BotMakers and is negotiating to acquire an AI-powered marketing leads company generating over $1 million in annual revenue. The acquisition strengthens BioQuest's position in enterprise-level AI solutions and automated digital workforce solutions for government, corporate, and law enforcement sectors.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.92%
Tags

FAQ

What is the current stock price of Bioquest (BQST)?

The current stock price of Bioquest (BQST) is $0.511 as of November 20, 2025.

What is the market cap of Bioquest (BQST)?

The market cap of Bioquest (BQST) is approximately 11.7M.

BQST Rankings

BQST Stock Data

11.66M
1.30M
Shell Companies
Financial Services
Link
United States
Katy

BQST RSS Feed